CRISPR and Genome Editing – Webinars and Online Events

Whether you're focused on advancing preclinical studies or optimizing large-scale manufacturing processes, this event promises to deliver actionable insights that can drive innovation and improve outcomes in your work.

In this webinar, our expert speaker Dr. Simon Reed from Broken Strings Bioscience will discuss the background to this industry-wide challenge and the need for technological advancements in this space.

In this webinar, you’ll gain insights from experts in CGT development who will explore their experiences of CQA assays, sharing advice on how to overcome the challenges you may face in your CGT journey.

In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.

CRISPR-Cas9 gene editing is an essential functional genomics tool, facilitating the cataloging of genomic variations linked to human diseases for the discovery and validation of novel drug targets.

A major challenge when developing AAV-based therapeutics is ensuring that empty AAVs that lack therapeutic DNA are removed, increasing the efficacy of the product.

In this webinar, our expert speaker Dr. Stefano Menegatti from NC State University, will discuss his team’s approach in leveraging affinity technology to introduce new tools for purifying and characterizing biotherapeutics to match the growing demands of clinics and biotech industries worldwide.

Colossal Biosciences is bringing back extinct animal species through genetic engineering, and using advanced biotechnology methods to help preserve endangered species. This process requires a large number of precision genome edits to be made in single cells that can be isolated, grown monoclonally, expanded, and re-edited. While Colossal generates mouse models to test some of these edits, typically the cell lines cultured are non-model organisms that are poorly characterized and require extensive optimization.

In this webinar we will discuss the challenges picking gene edited mouse embryonic stem cell colonies, and difficulties isolating monoclonal cell lines from non-model organisms. We will discuss automated alternatives to flow-sorting and manual colony picking with that improve single-cell outgrowth and increase gene editing efficiency.

In this webinar, you’ll discover how to evaluate cell and gene therapy genetic integrity and purity with optical genome mapping (OGM).

Explore the tools and techniques being used to study diseases in the lab. Discover how advances in cell culture and disease modeling are supporting diagnostic and therapeutic development.